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I.M. Loftus *, M.M. Thompson
St Georges Vascular Institute, London, UKThe classiﬁcation of aortic dissection has traditionally been
based on anatomical factors (the DeBakey and Stanford
classiﬁcations) and duration of symptoms prior to presen-
tation. The deﬁnition of acute (presentation within 14 days
of the onset of symptoms) and chronic has always been
somewhat arbitrary, though supported by observed differ-
ences in outcomes from both conservative management
and intervention. The advent of endovascular approaches,
especially for Type B dissection, has led to renewed interest
in the condition and in particular to the long term outcomes
relating to progression of disease and the degree of aortic
remodelling.
The current series published by Steuer et al. describes
a cohort of patients, undergoing treatment between 15-38
days of initial presentation.1 The outcomes from interven-
tion were signiﬁcantly better than in the acute group,
treated within 14 days of presentation, with no early deaths
or neurological complications. The authors suggest that this
represents a sub-acute phase in the transition from acute to
chronic and question the current deﬁnition based on a 14
day cut-off.
The Virtue Study also subdivided a cohort of 100 patients
with Type B Dissection undergoing thoracic endografting
into 3 subgroups, incorporating a sub-acute group with
intervention from 14-28 days.2 There was a signiﬁcant
reduction in peri-operative mortality and morbidity associ-
ated with intervention in the sub-acute period, with results
similar to those in the chronic group. The 3 year follow up
data will soon be presented which are likely to demonstrate
degrees of aortic remodelling very similar to acute dissec-
tion with low reintervention rates.
This raises a number of important issues with regard to
the classiﬁcation and management of acute type B dissec-
tion. Firstly, is it safer to intervene in the sub-acute period?
It is feasible that hypothesise that waiting 14 days may allow
stabilisation of the intimal tear, enabling the safer delivery of
endografts into an otherwise very fragile aorta. However,
the acute and sub-acute groups are non-comparable. In the
current series, they are signiﬁcantly younger, and a large
proportion present with rapid aortic dilatation rather than
impending or actual aortic rupture or malperfusion.DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.03.013
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http://dx.doi.org/10.1016/j.ejvs.2013.03.020Secondly, if it is safer to intervene in the sub-acute
phase, would this inﬂuence a more aggressive policy of
reintervention in the uncomplicated patients? The INSTEAD
trial randomised patients with uncomplicated type B
dissection to best medical therapy or early thoracic
endografting and failed to demonstrate and advantage for
early intervention.3 However, long term follow up data
have been presented demonstrating a signiﬁcant number
of patients in the best medical arm with sudden aortic
death. Clearly further work is required to establish a sub-
group of patients who may be most likely to beneﬁt from
early endografting.
Thirdly, do sub-acute dissections behave in the long term
in a similar manner to acute dissections? A number of
studies have demonstrated signiﬁcantly greater degrees of
favourable aortic remodelling in the acute dissection
compared to chronic, with diminution of the false lumen
and re-expansion of the acute lumen.4 This should ulti-
mately lead to improved long term outcomes in terms or
reintervention and aortic expansion. Longer term data are
clearly required to further guide clinical practice. In the
meantime, the current data do suggest a review of the
deﬁnitions of acute and chronic dissection, both in terms of
rationale for intervention, and presentation of long term
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